

Monday
May 12, 2025
8:00 AM ET
Annexon Reports First Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
Monday
March 3, 2025
8:00 AM ET
Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones
Monday
December 16, 2024
7:30 AM ET
Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)